Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 133

1.

Clinical and immunological differences between asymptomatic HDM-sensitized and HDM-allergic rhinitis patients.

Zidarn M, Robič M, Krivec A, Šilar M, Resch-Marat Y, Vrtala S, Kopač P, Bajrović N, Valenta R, Korošec P.

Clin Exp Allergy. 2019 Feb 7. doi: 10.1111/cea.13361. [Epub ahead of print]

PMID:
30734376
2.

Selection of house dust mite-allergic patients by molecular diagnosis may enhance success of specific immunotherapy.

Chen KW, Zieglmayer P, Zieglmayer R, Lemell P, Horak F, Bunu CP, Valenta R, Vrtala S.

J Allergy Clin Immunol. 2019 Mar;143(3):1248-1252.e12. doi: 10.1016/j.jaci.2018.10.048. Epub 2018 Nov 14. No abstract available.

3.

Underestimation of house dust mite-specific IgE with extract-based ImmunoCAPs compared with molecular ImmunoCAPs.

Huang HJ, Resch-Marat Y, Rodriguez-Dominguez A, Chen KW, Kiss R, Zieglmayer P, Zieglmayer R, Lemell P, Horak F, Valenta R, Vrtala S.

J Allergy Clin Immunol. 2018 Nov;142(5):1656-1659.e9. doi: 10.1016/j.jaci.2018.07.010. Epub 2018 Jul 27. No abstract available.

4.

Tropomyosins in mosquito and house dust mite cross-react at the humoral and cellular level.

Cantillo JF, Puerta L, Fernandez-Caldas E, Subiza JL, Soria I, Wöhrl S, Ebner C, Keller W, Resch-Marat Y, Vrtala S, Bohle B.

Clin Exp Allergy. 2018 Oct;48(10):1354-1363. doi: 10.1111/cea.13229. Epub 2018 Aug 14.

PMID:
29992665
5.

Betamethasone prevents human rhinovirus- and cigarette smoke- induced loss of respiratory epithelial barrier function.

Waltl EE, Selb R, Eckl-Dorna J, Mueller CA, Cabauatan CR, Eiwegger T, Resch-Marat Y, Niespodziana K, Vrtala S, Valenta R, Niederberger V.

Sci Rep. 2018 Jun 26;8(1):9688. doi: 10.1038/s41598-018-27022-y.

6.

Molecular Aspects of Allergens and Allergy.

Valenta R, Karaulov A, Niederberger V, Gattinger P, van Hage M, Flicker S, Linhart B, Campana R, Focke-Tejkl M, Curin M, Eckl-Dorna J, Lupinek C, Resch-Marat Y, Vrtala S, Mittermann I, Garib V, Khaitov M, Valent P, Pickl WF.

Adv Immunol. 2018;138:195-256. doi: 10.1016/bs.ai.2018.03.002. Epub 2018 Apr 26.

7.

Dysregulated invertebrate tropomyosin-dectin-1 interaction confers susceptibility to allergic diseases.

Gour N, Lajoie S, Smole U, White M, Hu D, Goddard P, Huntsman S, Eng C, Mak A, Oh S, Kim JH, Sharma A, Plante S, Salem IH, Resch Y, Xiao X, Yao N, Singh A, Vrtala S, Chakir J, Burchard EG, Lane AP, Wills-Karp M.

Sci Immunol. 2018 Feb 23;3(20). pii: eaam9841. doi: 10.1126/sciimmunol.aam9841.

PMID:
29475849
Free PMC Article
8.

Molecular allergen profiling in horses by microarray reveals Fag e 2 from buckwheat as a frequent sensitizer.

Einhorn L, Hofstetter G, Brandt S, Hainisch EK, Fukuda I, Kusano K, Scheynius A, Mittermann I, Resch-Marat Y, Vrtala S, Valenta R, Marti E, Rhyner C, Crameri R, Satoh R, Teshima R, Tanaka A, Sato H, Matsuda H, Pali-Schöll I, Jensen-Jarolim E.

Allergy. 2018 Jul;73(7):1436-1446. doi: 10.1111/all.13417. Epub 2018 Feb 27.

9.

Similar localization of conformational IgE epitopes on the house dust mite allergens Der p 5 and Der p 21 despite limited IgE cross-reactivity.

Curin M, Garmatiuk T, Resch-Marat Y, Chen KW, Hofer G, Fauland K, Keller W, Hemmer W, Vrtala S, Focke-Tejkl M, Valenta R.

Allergy. 2018 Aug;73(8):1653-1661. doi: 10.1111/all.13398. Epub 2018 Feb 21.

10.

Isolation of a high-affinity Bet v 1-specific IgG-derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments.

Gadermaier E, Marth K, Lupinek C, Campana R, Hofer G, Blatt K, Smiljkovic D, Roder U, Focke-Tejkl M, Vrtala S, Keller W, Valent P, Valenta R, Flicker S.

Allergy. 2018 Jul;73(7):1425-1435. doi: 10.1111/all.13394. Epub 2018 Feb 20.

11.

Recombinant allergen and peptide-based approaches for allergy prevention by oral tolerance.

Campana R, Huang HJ, Freidl R, Linhart B, Vrtala S, Wekerle T, Karaulov A, Valenta R.

Semin Immunol. 2017 Apr;30:67-80. doi: 10.1016/j.smim.2017.08.017. Epub 2017 Sep 20. Review.

PMID:
28939389
12.

House dust mites as potential carriers for IgE sensitization to bacterial antigens.

Dzoro S, Mittermann I, Resch-Marat Y, Vrtala S, Nehr M, Hirschl AM, Wikberg G, Lundeberg L, Johansson C, Scheynius A, Valenta R.

Allergy. 2018 Jan;73(1):115-124. doi: 10.1111/all.13260. Epub 2017 Sep 7.

13.

Innate function of house dust mite allergens: robust enzymatic degradation of extracellular matrix at elevated pH.

Oida K, Einhorn L, Herrmann I, Panakova L, Resch Y, Vrtala S, Hofstetter G, Tanaka A, Matsuda H, Jensen-Jarolim E.

World Allergy Organ J. 2017 Jul 4;10(1):23. doi: 10.1186/s40413-017-0154-3. eCollection 2017.

14.

Identification by serological proteome analysis of paramyosin as prominent allergen in dust mite allergy.

Conti A, Burastero GJ, Suli C, Banerjee S, Vrtala S, Alessio M, Burastero SE.

J Proteomics. 2017 Aug 23;166:19-26. doi: 10.1016/j.jprot.2017.06.024. Epub 2017 Jul 4.

PMID:
28687424
15.

International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem.

Sánchez-Borges M, Fernandez-Caldas E, Thomas WR, Chapman MD, Lee BW, Caraballo L, Acevedo N, Chew FT, Ansotegui IJ, Behrooz L, Phipatanakul W, Gerth van Wijk R, Pascal D, Rosario N, Ebisawa M, Geller M, Quirce S, Vrtala S, Valenta R, Ollert M, Canonica GW, Calderón MA, Barnes CS, Custovic A, Benjaponpitak S, Capriles-Hulett A.

World Allergy Organ J. 2017 Apr 18;10(1):14. doi: 10.1186/s40413-017-0145-4. eCollection 2017.

16.

Clinical validation of a house dust mite environmental challenge chamber model.

Zieglmayer P, Lemell P, Chen KW, Schmutz R, Zieglmayer R, Pfaar O, Horak F, Vrtala S.

J Allergy Clin Immunol. 2017 Jul;140(1):266-268.e5. doi: 10.1016/j.jaci.2016.12.986. Epub 2017 Feb 24. No abstract available.

PMID:
28238743
17.

Reliable mite-specific IgE testing in nasal secretions by means of allergen microarray.

Berings M, Arasi S, De Ruyck N, Perna S, Resch Y, Lupinek C, Chen KW, Vrtala S, Pajno GB, Bachert C, Lambrecht BN, Dullaers M, Valenta R, Matricardi PM, Gevaert P.

J Allergy Clin Immunol. 2017 Jul;140(1):301-303.e8. doi: 10.1016/j.jaci.2016.11.047. Epub 2017 Feb 21. No abstract available.

PMID:
28238352
18.

Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life.

Posa D, Perna S, Resch Y, Lupinek C, Panetta V, Hofmaier S, Rohrbach A, Hatzler L, Grabenhenrich L, Tsilochristou O, Chen KW, Bauer CP, Hoffman U, Forster J, Zepp F, Schuster A, Wahn U, Keil T, Lau S, Vrtala S, Valenta R, Matricardi PM.

J Allergy Clin Immunol. 2017 Feb;139(2):541-549.e8. doi: 10.1016/j.jaci.2016.08.014. Epub 2016 Oct 25.

PMID:
27793411
19.

Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen.

Resch Y, Blatt K, Malkus U, Fercher C, Swoboda I, Focke-Tejkl M, Chen KW, Seiberler S, Mittermann I, Lupinek C, Rodriguez-Dominguez A, Zieglmayer P, Zieglmayer R, Keller W, Krzyzanek V, Valent P, Valenta R, Vrtala S.

PLoS One. 2016 Aug 22;11(8):e0160641. doi: 10.1371/journal.pone.0160641. eCollection 2016.

20.

Real-Life Study for the Diagnosis of House Dust Mite Allergy - The Value of Recombinant Allergen-Based IgE Serology.

Becker S, Schlederer T, Kramer MF, Haack M, Vrtala S, Resch Y, Lupinek C, Valenta R, Gröger M.

Int Arch Allergy Immunol. 2016;170(2):132-7. doi: 10.1159/000447694. Epub 2016 Aug 10.

Supplemental Content

Loading ...
Support Center